These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29571859)

  • 1. Plasma citrulline levels are increased in patients with multiple sclerosis.
    Vande Vyver M; Beelen R; De Keyser J; Nagels G; Van Binst AM; Verborgh C; D'haeseleer M
    J Neurol Sci; 2018 Apr; 387():174-178. PubMed ID: 29571859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis.
    Marchetti G; Ziliotto N; Meneghetti S; Baroni M; Lunghi B; Menegatti E; Pedriali M; Salvi F; Bartolomei I; Straudi S; Manfredini F; Voltan R; Basaglia N; Mascoli F; Zamboni P; Bernardi F
    Mol Med; 2018 Aug; 24(1):42. PubMed ID: 30134823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
    Yang L; Tan D; Piao H
    Neurochem Res; 2016 Aug; 41(8):1845-56. PubMed ID: 27097548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
    Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
    Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
    Belogurov A; Zakharov K; Lomakin Y; Surkov K; Avtushenko S; Kruglyakov P; Smirnov I; Makshakov G; Lockshin C; Gregoriadis G; Genkin D; Gabibov A; Evdoshenko E
    Neurotherapeutics; 2016 Oct; 13(4):895-904. PubMed ID: 27324388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis.
    Negrotto L; Farez MF; Correale J
    JAMA Neurol; 2016 May; 73(5):520-8. PubMed ID: 26953870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
    Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R
    Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrulline-containing myelin basic protein is recognized by T-cell lines derived from multiple sclerosis patients and healthy individuals.
    Martin R; Whitaker JN; Rhame L; Goodin RR; McFarland HF
    Neurology; 1994 Jan; 44(1):123-9. PubMed ID: 7507225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
    Calabrese M; De Stefano N; Atzori M; Bernardi V; Mattisi I; Barachino L; Morra A; Rinaldi L; Romualdi C; Perini P; Battistin L; Gallo P
    Arch Neurol; 2007 Oct; 64(10):1416-22. PubMed ID: 17923625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
    Baranovicova E; Mlynarik V; Kantorova E; Hnilicova P; Dobrota D
    Neurol Res; 2016 May; 38(5):389-96. PubMed ID: 27078709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis.
    Bucova M; Majernikova B; Durmanova V; Cudrakova D; Gmitterova K; Lisa I; Klimova E; Kluckova K; Buc M
    Neurol Sci; 2020 Mar; 41(3):599-604. PubMed ID: 31728855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natalizumab therapy for highly active pediatric multiple sclerosis.
    Kornek B; Aboul-Enein F; Rostasy K; Milos RI; Steiner I; Penzien J; Hellwig K; Pitarokoili K; Storm van's Gravesande K; Karenfort M; Blaschek A; Meyer A; Seidl R; Debelic D; Vass K; Prayer D; Kristoferitsch W; Bayas A
    JAMA Neurol; 2013 Apr; 70(4):469-75. PubMed ID: 23420110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.